Sharp Corporation is an electronics manufacturer founded in 1912 and headquartered in Osaka Japan. Sharp has established itself as an industry leader in air conditioning, heating, and air purification in Japan since its first ductless mini-split in 1968. Sharp is seeking for more regional distributors to expand its heat pump business in North America after providing heating solutions for over 14 years in the area. Visit booth #SL1919 for further information. | Sharp is a leader in commercial packaging, clinical services & sterile manufacturing. For 70+ years, we’ve provided solutions to pharma & biotech clients from phase I trials through to commercial launch & lifecycle management. With facilities in the United States, United Kingdom, Belgium & the Netherlands and 30+ clinical depots globally, covering every region of the world, our experience is your strength. Our full complement of integrated services includes research and development, clinical manufacturing, small-scale sterile development and manufacturing services, primary and secondary packaging of both investigational and commercial product, package design, serialization and aggregation, storage, distribution and clinical IRT. Sharp also offers Qualified Person (QP) services to meet the complex regulatory demands of drug product release in the EU and UK. | Sharp is a leader in commercial packaging, clinical services & sterile manufacturing. For 70+ years, we’ve provided solutions to pharma & biotech clients from preclinical through to commercial launch & lifecycle management. With facilities in the United States, United Kingdom, Belgium & the Netherlands and 30+ clinical depots globally, covering every region of the world, our experience is your strength. Our full complement of integrated services includes research and development, clinical manufacturing, sterile development and fill/finish services, primary and secondary packaging of both investigational and commercial product, package design, serialization and aggregation, storage, distribution and clinical IRT. Sharp also offers Qualified Person (QP) services to meet the complex regulatory demands of drug product release in the EU and UK. | Sharp Imaging and Information Company of America (SIICA) is a division of Sharp Electronics Corporation, the U.S. subsidiary of Japan’s Sharp Corporation, a global technology company which has been named to Fortune magazine’s World’s Most Admired Company List. Sharp strives to help businesses achieve Simply Smarter work by helping companies manage workflow efficiently, create immersive and engaging environments, and increase productivity. SIICA offers a full suite of secure printer and copier solutions, commercial displays and projectors, Dynabook laptops, management and productivity software and fully managed services. As a total solutions provider, Sharp has a reputation for innovation, quality, reliability, and industry-leading customer support expertise. We look forward to seeing you at Infocomm 2025!
Richter BioLogics GmbH
Richter BioLogics stands at the forefront of Germany’s contract development and manufacturing sphere, with a specialized focus on products derived from bacteria and yeasts. Our three facilities boast capacities of 2 x 1,500L and 2 x 300L, facilitating the production of plasmid DNA, antibodies, including VHH/nanobodies, proteins, and vaccines. With over 35 years of proven success, our highly skilled teams are dedicated to supporting clients through every stage of production. We offer robust process development, supply products for clinical trials, oversee commercial production, conduct in-house quality control testing, and provide QP release. Our commitment to excellence is reflected in our adherence to the highest pharmaceutical quality standards, as verified by major regulatory bodies such as EMA, FDA, ANVISA, PMDA, and MFDS, alongside numerous customer audits. At Richter BioLogics, we pride ourselves on delivering reliable solutions with precision and expertise, ensuring our partners achieve their clinical and commercial goals with confidence. | Richter BioLogics stands at the forefront of contract development and manufacturing (CDMO) sphere, with a specialized focus on products derived from bacteria and yeasts. Our three facilities boast capacities of 2 x 1,500L and 2 x 300L, facilitating the production of antibodies, including VHH/Nanobodies, proteins, vaccines and plasmid DNA. With over 35 years of proven success, our highly skilled teams are dedicated to supporting clients through every stage of production. We offer robust process development, supply products for clinical trials, commercial production, conduct in-house quality control testing, and provide QP release. Our commitment to excellence is reflected in our adherence to the highest pharmaceutical quality standards, as verified by major regulatory bodies such as EMA, FDA, ANVISA, PMDA, and MFDS, alongside numerous customer audits. At Richter BioLogics, we pride ourselves on delivering reliable solutions with precision and expertise, ensuring our partners achieve their clinical and commercial goals with confidence and in time.
Reacta Healthcare
Reacta Healthcare is a specialist manufacturer of clinical trial materials for food allergy. Operating from a UK MHRA-licensed facility, the company produces GMP-grade products designed specifically for use in oral food challenge studies. Reacta supports global pharmaceutical and biotechnology companies in the development of food allergy therapies by enabling the safe, standardised and regulator-ready assessment of patient responses. With experience supporting programmes across Europe, the US and Asia, Reacta brings deep expertise in clinical trial requirements, allergen standardisation and regulatory expectations.
Pyramid Labs
SFF CDMO Aseptic Fill/Finish Services. Vial and Syringe Filling Lyophilization Analytical Services In-house Bioburden & Sterility Clinical & Commercial Manufacturing Stability Services Clinical & Commercial Labeling Breakloose/Glide Force testing. PPQ High Recovery Vials HRV US based manufacturing sites Drug Product CMC 510k Biologics mAb oligonucleotides peptides small molecules siRna nanoparticles Parenteral filling | Pyramid Pharma Services is a U.S.-based clinical-to-commercial fill-finish CDMO with over 26 years of GMP drug product manufacturing experience and more than 35 years in business. We provide aseptic manufacturing and sterile manufacturing solutions for complex injectable drug products, supporting both emerging biotech and established pharmaceutical companies. Our expertise includes oligonucleotides, peptides, biologics, and advanced therapeutics, with integrated capabilities that span formulation development, aseptic fill-finish, lyophilization, prefilled syringe and cartridge filling, device assembly, labeling, packaging, and analytical services. By offering end-to-end drug product manufacturing within a single organization, we reduce complexity, accelerate timelines, and ensure consistent execution from clinical development through commercial supply. Pyramid’s California-based facilities support flexible manufacturing across a range of batch sizes and delivery formats, including vials, prefilled syringes, and cartridges. Ongoing investment in advanced, high-speed fill-finish infrastructure strengthens our ability to deliver scalable, reliable solutions for increasingly complex injectable therapies. Our track record includes over 100 successful IND-enabling programs, multiple commercial products, and a strong history of FDA inspections—demonstrating a consistent focus on quality, compliance, and execution. As a fill-finish CDMO, we partner closely with our clients’ CMC, technical, and regulatory teams to support efficient development and commercialization. We work with companies developing injectable therapies that require a reliable, experienced partner for sterile fill-finish and aseptic drug product manufacturing. If you are advancing a program and evaluating a CDMO for fill-finish or drug product manufacturing, we welcome the opportunity to connect at BIO 2026. Schedule time with our team to discuss your program.
PSC Biotech
Founded in 1996, PSC Biotech Corporation is a global organization that has spent over two decades providing life science services and solutions through our professional service consultancy for CQV, CSV, auditing, IT services, and much more. PSC Software provides inspection/audit management and eQMS services and BioTechnique provides CRDMO services. We also distribute equipment (Lives International data loggers and thermal mapping systems). Since its inception, PSC has served as a strategic partner to emerging and established life science companies, helping them bring their life-saving products to market. | PSC Biotech® is a global specialty life sciences consultancy firms, supporting over 1000 clients in more than 35 countries. PSC Biotech Corporation® provides life science services and solutions through our professional service consultancy (CQV, CSA/CSV, Audit, and much more.) PSC Software® provides inspection management and electronic quality management systems that enable businesses to stay compliant while effectively and efficiently delivering products to market. PSC Software® has 4 proprietary, 21 CFR Part 11 compliant, cloud-based systems that accelerate and streamline quality processes. BioTechnique® is a division of PSC Biotech Corporation®. BioTechnique® is a Contract Research, Development, and Manufacturing Organization (CRDMO) that provides lyophilization and therapeutic sterile injectable fill-finish solutions to cater to both large and small investigational/clinical stage or commercial batch sizes. BioTechnique® provides a comprehensive platform for success, beginning with Formulation Studies, extending through Analytical and Formulation Development, and culminating in Product Launch (clinical or commercial). | . | BioTechnique is a CRDMO, pharmaceutical manufacturing facility located in York, PA. A highly potent sterile injectable and clinical oncolytics manufacturing company dedicated to providing cytotoxic and high potency sterile injectable fill-finish services. Our project management and client services staff work closely with clients to meet all their manufacturing needs. We provide formulation and compounding, fill-finish, lyophilization, shipping, storage, and 3rd party logistics for a wide variety of liquid injectables. BioTechnique utilizes our expertise to create process designs for client product needs. To learn more, visit www.biotechnique.com
PlasmidFactory GmbH
PlasmidFactory GmbH, established in 2000 in Bielefeld, Germany, is a premier contract development and manufacturing organization specializing in plasmid and minicircle DNA. We support clients and partners in cancer research, gene and cell therapy, and vaccination, with a focus on CAR-T cell development, AAV gene transfer, and minicircle tools for mRNA synthesis. We offer custom plasmid and minicircle DNA manufacturing services across various quality grades from Research and CCC grade up to High Quality grade and GMP certified material for clinical trials and applications. Our state-of-the-art facilities fulfil the highest quality standards, with full GMP services launching in Q4, 2025. Our extensive In-Stock product range supports immediate research needs, including AAV production plasmids and reporter constructs. At the forefront of Next Generation Gene Vectors, our R&D focuses on advancing our proprietary minicircle DNA technologies. Through strategic collaborations with global partners, we are committed to pioneering solutions for academia and the biopharmaceutical industry. – 25 years CDMO experience and innovation in plasmid and minicircle DNA – +3000 successful projects – From research grade to GMP – Talk to us to discuss how we can support your projects in the area of CGT, AAV or mRNA | PlasmidFactory GmbH, established in 2000 in Bielefeld, Germany, is a premier contract development and manufacturing organization specializing in plasmid and minicircle DNA. We support clients and partners in cancer research, gene and cell therapy, and vaccination, with a focus on CAR-T cell development, AAV gene transfer, and minicircle tools for mRNA synthesis. We offer custom plasmid and minicircle DNA manufacturing services across various quality grades from Research and CCC grade up to High Quality grade and GMP certified material for clinical trials and applications. Our state-of-the-art facilities fulfil the highest quality standards, with full GMP services launched in 2025. Our extensive In-Stock product range supports immediate research needs, including AAV production plasmids and reporter constructs. At the forefront of Next Generation Gene Vectors, our R&D focuses on advancing our proprietary minicircle DNA technologies. Through strategic collaborations with global partners, we are committed to pioneering solutions for academia and the biopharmaceutical industry. – 25 years CDMO experience and innovation in plasmid and minicircle DNA – +3000 successful projects – From research grade to GMP – Talk to us to discuss how we can support your projects in the area of CGT, AAV or mRNA
PAN-Biotech GmbH
PAN-Biotech is your trusted partner for OEM and CMO solutions in the biotech industry. With over 30 years of experience, we offer high-quality cell culture media, sera, and custom manufacturing sterile liquid solutions. Benefit from our expertise and expand your business in Europe with a reliable partner by your side. • Manufacturing (OEM, CMO, CDMO) • Upstream / Downstream • R&D for Cell Culture • Tailored Logistic Solutions Products & Services Our core strength is our flexibility, which enables us to provide customized solutions to partners in research and industry. This includes state-of-the-art cell culture products for research and preclinical applications, all manufactured according to ISO 13485. For clinical applications, we facilitate a seamless transition from RUO (Research Use Only) to EU GMP Annex 1, thereby supporting easy access to commercialization. Gateway to Europe with PAN-Biotech At PAN-Biotech, we understand the challenges when setting foot on a new continent. We are here to assist you every step of the way. From manufacturing and product storage to delivering your products to new customers, we provide comprehensive support to help you achieve your goals. | PAN-Biotech offers high-quality cell culture media, sera, and custom manufacturing sterile liquid solutions. This includes state-of-the-art cell culture products for research and preclinical applications, all manufactured according to ISO 13485. For clinical and industrial applications, we offer GMP grade products in accordance with GMP EU Annex 1.
OXB (formerly Oxford Biomedica)
OXB, formerly Oxford Biomedica, is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world. One of the original pioneers in cell and gene therapy, OXB has over 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. OXB’s world-class capabilities range from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise. OXB offers a vast number of technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the TetraVecta™ system), a dual-plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines. OXB, a FTSE250 and FTSE4Good constituent, is headquartered in Oxford, UK. It has development and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France, Bedford MA, and Durham NC, US. Learn more at www.oxb.com and follow us on LinkedIn and YouTube.
OranssiBio Ltd.
Oranssibio Ltd. | OranssiBio is a premier Contract Development and Manufacturing Organization (CDMO) strategically headquartered in Shanghai’s Free Trade Zone, specializing in advanced cell and gene therapies. We partner with biotech innovators and research institutions worldwide, delivering comprehensive, end-to-end solutions from early-stage development to clinical supply manufacturing and regulatory-compliant release. Our state-of-the-art, plug-and-play technology platforms support a diverse range of modalities, including: • Plasmid DNA • Lentivirus & Adeno-Associated Virus (AAV) • mRNA Therapeutics • Cell Therapies: CAR-T, TILs, NKs, iPSCs, and MSCs With a focus on quality, speed, and cost efficiency, OranssiBio accelerates the translation of groundbreaking therapies from bench to bedside, empowering our partners to bring life-changing treatments to patients faster and more effectively.